Sagacious IP Blog

Novartis 0

“Novartis AG v Union of India” Patent Case

In 2006, the Indian patent office had rejected the patent application for Novartis cancer drug, “Glivec” on grounds that – –    The original molecule imatinib was in public domain before 1995—the cut-off year...

patent-opposition 0

India: Patent Opposition System

The idea behind patent opposition is to restrain wrongful patent grants and claims of the petty inventions. So, under Indian Patent act, depending upon the stage of the patent, there are two provisions when...

patenting 0

Bio-printing –Patenting Issues & Benefits

3D printing, also known as additive engineering is a process of making three dimensional solid objects from a digital model. It is used to manufacture metal, ceramics, glass, and numerous other elements of the...